23andMe Co-Founder and CEO Anne Wojcicki explains how the personal-genomics company was built on the premise that consumers shouldn't be dependent on a profit-driven healthcare system. She recalls questioning why consumers relied on doctors and drug companies at a time when the increasing availability of information online, and connectedness, promised to empower people to manage their own health.

23andMe Co-Founder Anne Wojcicki talks about the intense scrutiny that her company received from regulators when its DNA testing kits debuted. The fact that they were sold directly to consumers raised the most controversy, just as birth-control tests once did, according to Wojcicki. The Federal Drug Administration's warning, she says, was an encouraging sign: "To really drive change, you have to change the system."

23andMe CEO Anne Wojcicki discusses how the DNA-testing company asks every customer whether or not they want to share their genetic information for research. She says the vast majority of them consent to having their data included in scientific studies. "There's no such thing as a healthy person," Wojcicki explains. "Everyone has something, and so, we all want to help each other."

23andMe's Anne Wojcicki describes how partnering with retail chains like Walmart and Walgreen's - and not hospitals - is to be present in people's everyday ecosystem. Health is largely influenced by everyday decisions, and shopping is more common in daily life than a visit to your physician, according to Wojcicki. "The future of prevention is not with your doctor," she says. "The future of prevention is with Walmart."

Anne Wojcicki, co-founder and CEO of 23andMe, talks about how ethical concerns over genetic research sometimes stem from science fiction. She uses the example of recent breakthroughs in gene editing, and how, despite existing knowledge about genetic disorders, we still can't use innovations like "CRISPR" to cure them. That, Wojcicki says, fuels her passion to completely understand the human genome.